(Post-pandemic Era)-Global Long-acting Injectable Medications Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027 | Analytical Research Cognizance

(Post-pandemic Era)-Global Long-acting Injectable Medications Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027

Published by ARCXZ001
Report ID 1664920
Published date Mar 09, 2021
Category Pharmaceuticals and Healthcare
Total Pages 117
Choose license type Buy Now
Request a Sample Enquiry Before Buying Check Discount

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Long-acting Injectable Medications market in this environment.

In terms of revenue, this research report indicated that the global Long-acting Injectable Medications market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Long-acting Injectable Medications industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Eli Lilly aims at producing XX K Units Long-acting Injectable Medications in 2020, with XX % production to take place in global market, Nanomi accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Long-acting Injectable Medications Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America

Competitive Analysis; Who are the Major Players in Long-acting Injectable Medications Market?
Eli Lilly
Nanomi
Alkermes
Zogenix
DURECT
Johnson & Johnson
MedinCell
Mapi Pharma
Oakwood Labs
GSK
Pharmathen
Kashiv BioSciences
...

Major Type of Long-acting Injectable Medications Covered in XYZResearch report:
First-generation
Second-generation

Application Segments Covered in XYZResearch Market
Schizophrenia
Contraception
HIV
Other

For any other requirements, please feel free to contact us and we will provide you customized report.

Chapter One: Market Scope
1.1 Product Details and Introduction
1.1.1 First-generation -Product Introduction and Major Manufacturers
1.1.2 Second-generation -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

Chapter Two: Global Long-acting Injectable Medications Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)

Chapter Three: Regional Market Analysis
3.1 China Long-acting Injectable Medications Market
3.1.1 Top Companies leading Long-acting Injectable Medications Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Long-acting Injectable Medications Market
3.2.1 Top Companies leading Long-acting Injectable Medications Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Long-acting Injectable Medications Market
3.3.1 Top Companies leading Long-acting Injectable Medications Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Long-acting Injectable Medications Market
3.4.1 Top Companies leading Long-acting Injectable Medications Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Long-acting Injectable Medications Market
3.5.1 Top Companies leading Long-acting Injectable Medications Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Long-acting Injectable Medications Market
3.6.1 Top Companies leading Long-acting Injectable Medications Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Long-acting Injectable Medications Market
3.7.1 Top Companies leading Long-acting Injectable Medications Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)

Chapter Four: Value Chain (Impact of COVID-19)
4.1 Long-acting Injectable Medications Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Long-acting Injectable Medications Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors

Chapter Five: Regional Market Forecast (2021-2027)
5.1 Global Long-acting Injectable Medications Sales and Growth Rate (2021-2027)
5.2 Global Long-acting Injectable Medications Sales Value and Growth Rate (2021-2027)

Chapter Six: Long-acting Injectable Medications Competitive Analysis
6.1 Eli Lilly
6.1.1 Eli Lilly Company Profiles
6.1.2 Eli Lilly Product Introduction
6.1.3 Eli Lilly Long-acting Injectable Medications Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Nanomi
6.2.1 Nanomi Company Profiles
6.2.2 Nanomi Product Introduction
6.2.3 Nanomi Long-acting Injectable Medications Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Alkermes
6.3.1 Alkermes Company Profiles
6.3.2 Alkermes Product Introduction
6.3.3 Alkermes Long-acting Injectable Medications Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Zogenix
6.4.1 Zogenix Company Profiles
6.4.2 Zogenix Product Introduction
6.4.3 Zogenix Long-acting Injectable Medications Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 DURECT
6.5.1 DURECT Company Profiles
6.5.2 DURECT Product Introduction
6.5.3 DURECT Long-acting Injectable Medications Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Profiles
6.6.2 Johnson & Johnson Product Introduction
6.6.3 Johnson & Johnson Long-acting Injectable Medications Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 MedinCell
6.7.1 MedinCell Company Profiles
6.7.2 MedinCell Product Introduction
6.7.3 MedinCell Long-acting Injectable Medications Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Mapi Pharma
6.8.1 Mapi Pharma Company Profiles
6.8.2 Mapi Pharma Product Introduction
6.8.3 Mapi Pharma Long-acting Injectable Medications Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Oakwood Labs
6.9.1 Oakwood Labs Company Profiles
6.9.2 Oakwood Labs Product Introduction
6.9.3 Oakwood Labs Long-acting Injectable Medications Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 GSK
6.10.1 GSK Company Profiles
6.10.2 GSK Product Introduction
6.10.3 GSK Long-acting Injectable Medications Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Pharmathen
6.12 Kashiv BioSciences

Chapter Seven: Conclusion

List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021)
Figure Global Long-acting Injectable Medications Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2027)
Table CAGR in Terms of Production of Each Type (2026-2027)
Table CAGR in Terms of Production of Each Application (2026-2027)
Table Global Long-acting Injectable Medications Sales (K Unit) by Type (2026-2027)
Figure Global Long-acting Injectable Medications Sales (K Unit) and Growth Rate (2026-2027)
Figure Global Long-acting Injectable Medications Sales Market Share (%) by Type (2019 -2020)
Table Global Long-acting Injectable Medications Sales Value (Million USD) by Type (2026-2027)
Figure Global Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2026-2027)
Figure Global Long-acting Injectable Medications Sales Value Market Share (%) by Type (2019-2020)
Table Global Long-acting Injectable Medications Sales (K Unit) by Application (2026-2027)
Table China Long-acting Injectable Medications Sales (K Unit) of Major Company (2016-2021)
Table China Long-acting Injectable Medications Sales Market Share of Major Company (2016-2021)
Table China Long-acting Injectable Medications Sales Value (Million USD) of Major Company (2016-2021)
Figure China Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2016-2021)
Table China Long-acting Injectable Medications Sales Value Share of Major Company (2016-2021)
Table China Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
Table China Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Figure China Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Table EU Long-acting Injectable Medications Sales (K Unit) of Major Company (2016-2021)
Table EU Long-acting Injectable Medications Sales Market Share of Major Company (2016-2021)
Table EU Long-acting Injectable Medications Sales Value (Million USD) of Major Company (2016-2021)
Figure EU Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2016-2021)
Table EU Long-acting Injectable Medications Sales Value Share of Major Company (2016-2021)
Table EU Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
Table EU Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Figure EU Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Table USA Long-acting Injectable Medications Sales (K Unit) of Major Company (2016-2021)
Table USA Long-acting Injectable Medications Sales Market Share of Major Company (2016-2021)
Table USA Long-acting Injectable Medications Sales Value (Million USD) of Major Company (2016-2021)
Figure USA Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2016-2021)
Table USA Long-acting Injectable Medications Sales Value Share of Major Company (2016-2021)
Table USA Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
Table USA Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Figure USA Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Table Japan Long-acting Injectable Medications Sales (K Unit) of Major Company (2016-2021)
Table Japan Long-acting Injectable Medications Sales Market Share of Major Company (2016-2021)
Table Japan Long-acting Injectable Medications Sales Value (Million USD) of Major Company (2016-2021)
Figure Japan Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2016-2021)
Table Japan Long-acting Injectable Medications Sales Value Share of Major Company (2016-2021)
Table Japan Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
Table Japan Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Figure Japan Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Table India Long-acting Injectable Medications Sales (K Unit) of Major Company (2016-2021)
Table India Long-acting Injectable Medications Sales Market Share of Major Company (2016-2021)
Table India Long-acting Injectable Medications Sales Value (Million USD) of Major Company (2016-2021)
Figure India Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2016-2021)
Table India Long-acting Injectable Medications Sales Value Share of Major Company (2016-2021)
Table India Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
Table India Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Figure India Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Table Southeast Asia Long-acting Injectable Medications Sales (K Unit) of Major Company (2016-2021)
Table Southeast Asia Long-acting Injectable Medications Sales Market Share of Major Company (2016-2021)
Table Southeast Asia Long-acting Injectable Medications Sales Value (Million USD) of Major Company (2016-2021)
Figure Southeast Asia Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2016-2021)
Table Southeast Asia Long-acting Injectable Medications Sales Value Share of Major Company (2016-2021)
Table Southeast Asia Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
Table Southeast Asia Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Figure Southeast Asia Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Table South America Long-acting Injectable Medications Sales (K Unit) of Major Company (2016-2021)
Table South America Long-acting Injectable Medications Sales Market Share of Major Company (2016-2021)
Table South America Long-acting Injectable Medications Sales Value (Million USD) of Major Company (2016-2021)
Figure South America Long-acting Injectable Medications Sales Value (Million USD) and Growth Rate (2016-2021)
Table South America Long-acting Injectable Medications Sales Value Share of Major Company (2016-2021)
Table South America Long-acting Injectable Medications Price (USD/Unit), by Type (2019-2020)
Table South America Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Figure South America Long-acting Injectable Medications Sales (Unit) by Type (2026-2027)
Figure Value Chain Structure of Long-acting Injectable Medications
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Long-acting Injectable Medications
Figure Cost Structure of Long-acting Injectable Medications in 2020
Table Distributors/Traders List
Table Regional Market Sales (K Unit) (2021-2027)
Table Regional Market Sales Share (2021-2027)
Figure Global Long-acting Injectable Medications Sales (Unit), Growth Rate & Market Share (2021-2027)
Table Regional Market Sales Value (Million USD) (2021-2027)
Table Regional Market Sales Value Share (2021-2027)
Figure Global Long-acting Injectable Medications Sales Value (Million USD), Growth Rate & Market Share (2021-2027)
Table Eli Lilly Profiles
Table Eli Lilly Long-acting Injectable Medications Product Introduction
Table Eli Lilly Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure Eli Lilly SWOT Analysis
Table Nanomi Profiles
Table Nanomi Long-acting Injectable Medications Product Introduction
Table Nanomi Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure Nanomi SWOT Analysis
Table Alkermes Profiles
Table Alkermes Long-acting Injectable Medications Product Introduction
Table Alkermes Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure Alkermes SWOT Analysis
Table Zogenix Profiles
Table Zogenix Long-acting Injectable Medications Product Introduction
Table Zogenix Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure Zogenix SWOT Analysis
Table DURECT Profiles
Table DURECT Long-acting Injectable Medications Product Introduction
Table DURECT Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure DURECT SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Long-acting Injectable Medications Product Introduction
Table Johnson & Johnson Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure Johnson & Johnson SWOT Analysis
Table MedinCell Profiles
Table MedinCell Long-acting Injectable Medications Product Introduction
Table MedinCell Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure MedinCell SWOT Analysis
Table Mapi Pharma Profiles
Table Mapi Pharma Long-acting Injectable Medications Product Introduction
Table Mapi Pharma Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure Mapi Pharma SWOT Analysis
Table Oakwood Labs Profiles
Table Oakwood Labs Long-acting Injectable Medications Product Introduction
Table Oakwood Labs Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure Oakwood Labs SWOT Analysis
Table GSK Profiles
Table GSK Long-acting Injectable Medications Product Introduction
Table GSK Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure GSK SWOT Analysis
Table Pharmathen Profiles
Table Pharmathen Long-acting Injectable Medications Product Introduction
Table Pharmathen Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
Figure Pharmathen SWOT Analysis
Table Kashiv BioSciences Profiles
Table Kashiv BioSciences Long-acting Injectable Medications Product Introduction
Table Kashiv BioSciences Long-acting Injectable Medications Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)